|4Jan 4, 4:09 PM ET

English Edward C 4

4 · Xilio Therapeutics, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2023-01-01
English Edward C
Principal Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-01+24,00024,000 total
    Exercise: $2.69Exp: 2032-12-31Common Stock (24,000 underlying)
Footnotes (1)
  • [F1]The option award was granted on January 1, 2023 and shall vest on February 1, 2023 with respect to 1/48th of the shares of common stock underlying the stock option and shall continue to vest in equal monthly installments thereafter until January 1, 2027.

Documents

1 file
  • 4
    form4-01042023_090144.xmlPrimary